期刊文献+

沙利度胺抑制高脂诱导的炎性因子表达 被引量:1

Thalidomide Inhibits the Expression of Inflammation Factors Induced by High Lipid Diet
下载PDF
导出
摘要 目的研究沙利度胺对高脂诱导的炎症因子表达的影响,进一步明确其抗动脉粥样硬化(As)的机制。方法健康新西兰兔36只,随机分为正常组、高脂组、沙利度胺组,酶联免疫吸附法(ELISA)检测血液中肿瘤坏死因子α(TNF-α)、白细胞介素8(IL-8)和IL-1水平;罗氏生物化学仪检测总胆固醇(TC)、高密度脂蛋白(HDL)、甘油三酯(TG)含量。苏丹IV染色检测主动脉As病变面积,HE染色检测As病变程度。结果高脂组TNF-α、IL-8和IL-1β水平比正常组显著升高(P<0.05)。沙利度胺组TNF-α、IL-8和IL-1水平比高脂组显著降低(P<0.05)。高脂组和沙利度胺组TC、HDL和TG较正常组明显升高,但两者之间差异无显著性。苏丹IV染色和HE染色发现高脂组有明显的As病变存在,沙利度胺组As病变面积和病变程度都明显减轻。结论沙利度胺通过抑制高脂诱导的炎性因子表达而非降脂效应抑制As的形成。 Objective To study the influence of thalidomide ( Thd ) on the expression of inflammatory factors, and explore the mechanism of thalidomide inhibiting atherosclerogenesis. Methods After serum collected, TNF - α,IL - 8 and IL - 1 levels were analyzed by ELISA kits, and total cholesterol ( TC ), high density lipoprotein ( HDL), and triglyceride ( TG ) were detected by kits too. After the whole aorta was free, Sudan IV staining was used to visualize the atherosclerotic plaque area. HE staining was used to define the character of atherosclerotic plaque. Results Inflammatory response was induced by high lipid diet, which was confirmed by high level TNF - α, IL - 8 and IL - 1 in high lipid diet group compared with normal diet group. The expression of inflammatory factors was inhibited by thalidomide obviously, which was confirmed by low level TNF - α, IL - 8 and IL - 1 in high lipid diet group compared with high lipid diet added with drug group. Compared with high cholesterol group, the content of TC, LDL, HDL, TG in Thd group had no statistical difference. Athesosclerotic lesions existed in high lipid diet group. The size and the degree of athesosclerotic lesions decreased in high lipid diet added with drug group compared with high lipid diet group. Conclusion Thalidomide can inhibit the expression of inflammatory factors, which may be the important mechanism of thalidomide inhibiting atherosclerogenesis.
出处 《南华大学学报(医学版)》 2010年第4期461-464,共4页 Journal of Nanhua University(Medical Edition)
关键词 沙利度胺 炎性因子 动脉粥样硬化 新西兰兔 thalidomide inflammation atherosclerosis New Zealand rabbit
  • 相关文献

参考文献12

  • 1Ross R.Atherosclerosis--an inflammatory disease[J].N Engl J Med,1999,340(2):115 -126.
  • 2Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105 (9):1135-1143.
  • 3Robbie L,Libby P.Inflammation and atherothrombosis[J].Ann N Y Acad Sci,2001,947:167 -179.
  • 4Ito T,Ikeda U.Inflammatory cytokines and cardiovascular disease[J].Curr Drug Targets Inflamm Allergy,2003,2(3):257 -265.
  • 5Ye Q,Chen B,Tong Z,et al.Thalidomide reduces IL-18,IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease[J].Eur Respir J,2006,28 (4):824-831.
  • 6Dmoszynska A,Podhorecka M,Manko J,et al.The influence of thalidomide therapy on cytokine secretion,immunophenotype,BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma[J].Neoplasma,2005,52(2):175-181.
  • 7Paravar T,Lee DJ.Thalidomide:mechanisms of action[J].Int Rev Immunol,2008;27(3):111-135.
  • 8刘录山,潘利红,杨琼,武春艳,江璐,唐志晗,王佐,姜志胜.沙利度胺对高脂饮食兔动脉粥样硬化病变形成的抑制作用[J].中国动脉硬化杂志,2009,17(1):4-8. 被引量:6
  • 9Zhang R,Maratos-Flier E,Flier JS.Reduced adiposity and high-fat diet-Induced adipose inflammation in mice deficient for phosphodiesterase 4B[J].Endocrinology,2009,150 (7):3076-3082.
  • 10J Todoric,M L(o)ffler,J Huber,et al.Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n -3 polyunsaturated fatty acids[J].Diabetologia,2006,49(9):2109 -2119.

二级参考文献15

  • 1范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:73
  • 2Ross R. Atherosclerosis--an inflammatory disease [ J ]. N Engl J Med, 1999, 340 (2) : 115-126.
  • 3Libby P, Ridker PM, Maseri A. Inflammation and atherosclemsis [ J ]. Circulation, 2002, 105 (9) : 1 135-143.
  • 4Robbie L, Libby P. Inflammation and atherothrombosis [J]. Ann NY Acad Sci, 2001,947: 167-179.
  • 5Joki T, Vaananen I, Th~didomide and embryopathies. Report of 2 cases [J]. Duodecim, 1962, 78: 822-827.
  • 6Smtthes RW. 'ltlalidomide and malformations in Liverpool [J]. Lancet, 1962, 1(7 242): 1 270-273.
  • 7Ye Q, Chen B, Tong Z, et al. Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrcphages in interstitial lung disease [J]. Eur Respir J, 2006, 28 (4) :824-831.
  • 8Dmoszynska A, Podhorecka M, Manko J, et ah The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma [J]. Neoplasma, 2005, 52 (2) : 175-181.
  • 9Paravar T, Lee DJ. Thalidomide: mechanisms of action [ J ]. Int Rev Immunol, 2008, 27 (3) : 111-135.
  • 10Yasui K, Kobayashi N, Yamazaki T, et al. Thalidomide as an immunotherapeutic agent : the effects on neutrophil-mediated inflammation [ J]. CurrPharm Des, 2005, 11 (3) : 395-401.

共引文献8

同被引文献20

  • 1Weitz-Schmidt G, Welzenbach K, Brinkmann V, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site [J]. Nat Med, 2001, 7 (6): 687-692.
  • 2Pruefer D, Makowski J, Dahm M, et al. Aprotinin inhibits leukocyte-endothelial cell interactions after hemorrhage and reperfusion [J]. Ann Thorac Surg, 2003, 75 (1): 210-216.
  • 3Qiao H, Sanders RD, Ma D, et al. Sedation improves early outcome in severely septic Sprague Dawley rats [J]. Crit Care, 2009, 13 (4) : R136.
  • 4Raju J, Bird RP. Energy restriction reduces the number of advanced aberrant crypt loci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats [J]. Cancer Res, 2003, 63 (20): 6595-6601.
  • 5Morel O, Toti F,. Morel N, et al. Microparticles in endothelial cell and vascular homeostasis: are they really noxious? [J]. Haematologica, 2009, 94 (3): 313-317.
  • 6Mortaza S, Martinez MC, Baron-Menguy C, et al. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats [Jl. Crit Care Med, 2009, 37 (6): 2045- 2050.
  • 7Stefanec T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? [ J]. Chest, 2000, 117 (3) : 841-854.
  • 8Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis [J]. Circulation, 2004, 109 (21): 2560- 2565.
  • 9Kruger P, Fitzsimmons K, Cook D, et al. Statin therapy is associated with fewer deaths in patients with bacteraemia [ J 1. Intensive Care Med, 2006, 32 (1) : 75-79.
  • 10Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis [ J ]. Circulation, 2004, 110 (7): 880-885.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部